Literature DB >> 25478921

Nonalcoholic fatty liver disease and fibrosis progression: the good, the bad, and the unknown.

Stephen A Harrison1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25478921     DOI： 10.1016/j.cgh.2014.11.024

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  6 in total

Review 1.  Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.

Authors:  Luan Rodrigues Abdallah; Ricardo Cardoso de Matos; Yves Pacheco Dias March E Souza; Débora Vieira-Soares; Gabriela Muller-Machado; Priscila Pollo-Flores
Journal:  Curr Atheroscler Rep       Date:  2020-02-04       Impact factor: 5.113

Review 2.  Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.

Authors:  Paul D Berk; Elizabeth C Verna
Journal:  Clin Liver Dis       Date:  2016-02-18       Impact factor: 6.126

3.  Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.

Authors:  Miwa Kawanaka; Ken Nishino; Yumiko Morimoto; Katsunori Ishii; Tomohiro Tanikawa; Noriyo Urata; Mitsuhiko Suehiro; Takako Sasai; Ken Haruma; Hirofumi Kawamoto
Journal:  Intern Med       Date:  2020-12-07       Impact factor: 1.271

Review 4.  NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?

Authors:  Cristiane A Villela-Nogueira; Nathalie C Leite; Claudia R L Cardoso; Gil F Salles
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

Review 5.  Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation.

Authors:  Elizabeth M Brunt
Journal:  Hepatol Commun       Date:  2017-06-07

6.  A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis.

Authors:  Andrea Dennis; Sofia Mouchti; Matt Kelly; Jonathan A Fallowfield; Gideon Hirschfield; Michael Pavlides; Rajarshi Banerjee
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.